October 17, 2026 04:26 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
'How dare Elon Musk?' Owaisi defends Modi after billionaire's 'real boss' jibe at Ambani | 'B****y S***': IAS officer's abuse of female colleague during virtual J&K meeting sparks row | Aamir Khan’s nephew Imran Khan asked to leave India by Oct 28 after joining anti-CEC protest | ‘Their crime? Demanding justice’: Rahul Gandhi slams 4 AM detention of Ankita Bhandari’s parents | ‘Bangladesh showed us the way’: Neha Bora’s remarks spark BJP attack on Rahul Gandhi | Chingrighata flyover skid scare: Bikes fall, anti-skid blocks installed overnight as Bengal Minister Agnimitra Paul faces criticism | Meerut blue drum murder case: Muskaan, her lover get death sentence | 'Rise up, young patriots!': American singer Mary Millben alleges CJP gets US funding, urges peaceful protests | 'Won't go unchallenged': Muhammad Yunus heckling in New York triggers legal action warning | flydubai cockpit attack probe widens: Two Maldivian pilots detained in UAE over links to Omani co-pilot
Stock Market
Representational Photo: ChatGPT

Market update: Sensex tumbles 120 points, Nifty below 25,850 at closing bell

| @indiablooms | Dec 17, 2025, at 04:00 pm

Mumbai/IBNS: The Indian stock market ended Wednesday on a negative note, with BSE Sensex falling 120 points and NSE Nifty 50 closing below 25,850. Sensex settled at 84,559.65, while Nifty finished at 25,818.55.

Among sector movers, HDFC Bank, ICICI Bank, Asian Paints, and Titan were top losers, while shares of Maruti, TCS, Tata Steel, Reliance, and Bharti Airtel witnessed gains.

The Indian rupee, which opened at a fresh low, rebounded to settle at ₹90.38 against the US dollar, marking a 0.7% gain—the biggest single-day rise since October 15.

Meanwhile, dialysis service provider Nephrocare Health Services made a strong stock market debut, listing at a premium of about 7%. The shares debuted at ₹491.70 on the BSE (6.8% premium) and ₹490 on the NSE (6.52% premium), according to CNBC-TV18.

Nephrocare’s ₹871.05-crore initial public offering (IPO), open for subscription from December 10–12, was oversubscribed 13.96 times, highlighting strong investor demand.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.